Inhibits selectively the ET-1 binding to the ETB receptor.
Product Specification
| Formula: | C103H115N23O23 |
| |
| MW: | 2043.2 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Sequence: | Gly-Asn-Trp-His-Gly-Thr-Ala-Pro-Asp-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp-OH (Beta peptide bond between Gly1and Asp9). |
| |
| Formulation: | Lyophilized. |
| |
| Peptide Content: | 75-90% |
| |
| Solubility: | Soluble in DMSO (5mg/ml); dilute with 0.6ml distilled water. |
| |
| Long Term Storage: | -20°C |
| |
Product Literature References
J.X. He, et al.; Bioorg. Med. Chem. Lett. 5, 621 (1995),
RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. I. Characterization of producing strain, fermentation, isolation, physico-chemical and biological properties: Y. Morishita, et al.; J. Antibiot.
47, 269 (1994),
Abstract;
Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction: S.A. Sudjarwo, et al.; BBRC
200, 627 (1994),
Abstract;